Immunobiology Laboratory, Department of Zoology, University of Delhi, Delhi, 110 007, India.
Indian J Tuberc. 2021 Jul;68(3):321-329. doi: 10.1016/j.ijtb.2020.11.011. Epub 2020 Nov 24.
Tuberculosis (TB) is global, one of the most fatal communicable diseases and leading cause of worldwide mortality. One-third of the global population is latently affected by Mtb (Mycobacterium tuberculosis) due to its ability to circumvent the host's immune response for its own survival. MicroRNAs (miRNAs) are small, non-coding RNAs which function at the post-transcriptional level and are critical in fine-tuning immune responses regulating the repertoire of genes expressed in immune cells. Recent studies have established their crucial role against TB. Furthermore, the differential expression pattern of miRNAs has revealed the potential role of miRNAs as biomarkers which could be utilized to differentiate between healthy controls and active TB patients or between active and latent TB. The recent advancements made in the field of miRNA regulation of the host responses against TB, as well as the potential of miRNAs as biomarkers for TB diagnosis are discussed here in this review.
结核病(TB)是一种全球性疾病,是最致命的传染病之一,也是全球死亡的主要原因。由于结核分枝杆菌(Mycobacterium tuberculosis)能够逃避宿主的免疫反应以维持自身生存,全球有三分之一的人口受到潜伏性结核分枝杆菌的影响。微小 RNA(miRNA)是一种小的非编码 RNA,在转录后水平发挥作用,对于精细调节免疫反应、调节免疫细胞中基因表达谱至关重要。最近的研究已经确定了它们在结核病中的关键作用。此外,miRNA 的差异表达模式揭示了 miRNA 作为生物标志物的潜在作用,可用于区分健康对照者和活动性结核病患者,或区分活动性和潜伏性结核病。本文综述了 miRNA 对宿主抗结核反应的调控作用的最新进展,以及 miRNA 作为结核病诊断生物标志物的潜力。